These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 33303029)

  • 1. CD44 as a tumor biomarker and therapeutic target.
    Xu H; Niu M; Yuan X; Wu K; Liu A
    Exp Hematol Oncol; 2020 Dec; 9(1):36. PubMed ID: 33303029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44 and its implication in neoplastic diseases.
    Xu Y; Bai Z; Lan T; Fu C; Cheng P
    MedComm (2020); 2024 Jun; 5(6):e554. PubMed ID: 38783892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44: A New Prognostic Marker in Colorectal Cancer?
    Ziranu P; Pretta A; Aimola V; Cau F; Mariani S; D'Agata AP; Codipietro C; Rizzo D; Dell'Utri V; Sanna G; Moledda G; Cadoni A; Lai E; Puzzoni M; Pusceddu V; Castagnola M; Scartozzi M; Faa G
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biology and role of CD44 in cancer progression: therapeutic implications.
    Chen C; Zhao S; Karnad A; Freeman JW
    J Hematol Oncol; 2018 May; 11(1):64. PubMed ID: 29747682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of CD44 in epithelial-mesenchymal transition and cancer development.
    Xu H; Tian Y; Yuan X; Wu H; Liu Q; Pestell RG; Wu K
    Onco Targets Ther; 2015; 8():3783-92. PubMed ID: 26719706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer.
    Thapa R; Wilson GD
    Stem Cells Int; 2016; 2016():2087204. PubMed ID: 27200096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal splice isoform of CD44 (CD44s) promotes EMT/invasion and imparts stem-like properties to ovarian cancer cells.
    Bhattacharya R; Mitra T; Ray Chaudhuri S; Roy SS
    J Cell Biochem; 2018 Apr; 119(4):3373-3383. PubMed ID: 29130517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CD44 standard isoform contributes to radioresistance of pancreatic cancer cells.
    Tsubouchi K; Minami K; Hayashi N; Yokoyama Y; Mori S; Yamamoto H; Koizumi M
    J Radiat Res; 2017 Nov; 58(6):816-826. PubMed ID: 29106581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoform switch of CD44 induces different chemotactic and tumorigenic ability in gallbladder cancer.
    Miwa T; Nagata T; Kojima H; Sekine S; Okumura T
    Int J Oncol; 2017 Sep; 51(3):771-780. PubMed ID: 28677740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells.
    Preca BT; Bajdak K; Mock K; Sundararajan V; Pfannstiel J; Maurer J; Wellner U; Hopt UT; Brummer T; Brabletz S; Brabletz T; Stemmler MP
    Int J Cancer; 2015 Dec; 137(11):2566-77. PubMed ID: 26077342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer.
    Tjhay F; Motohara T; Tayama S; Narantuya D; Fujimoto K; Guo J; Sakaguchi I; Honda R; Tashiro H; Katabuchi H
    Cancer Sci; 2015 Oct; 106(10):1421-8. PubMed ID: 26250934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial to mesenchymal transition might be induced via CD44 isoform switching in colorectal cancer.
    Mashita N; Yamada S; Nakayama G; Tanaka C; Iwata N; Kanda M; Kobayashi D; Fujii T; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Kodera Y
    J Surg Oncol; 2014 Nov; 110(6):745-51. PubMed ID: 24975268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-to-mesenchymal transition through β-catenin/Erk/Akt signaling in gastric cancer.
    Geng B; Pan J; Zhao T; Ji J; Zhang C; Che Y; Yang J; Shi H; Li J; Zhou H; Mu X; Xu C; Wang C; Xu Y; Liu Z; Wen H; You Q
    J Exp Clin Cancer Res; 2018 Aug; 37(1):208. PubMed ID: 30165890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of tumor initiation is dependent on CD44s in c-Met⁺ hepatocellular carcinoma.
    Dang H; Steinway SN; Ding W; Rountree CB
    BMC Cancer; 2015 Mar; 15():161. PubMed ID: 25886575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44: structure, function, and association with the malignant process.
    Naor D; Sionov RV; Ish-Shalom D
    Adv Cancer Res; 1997; 71():241-319. PubMed ID: 9111868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
    Geng S; Guo Y; Wang Q; Li L; Wang J
    Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are CD44 variant isoforms involved in human tumour progression?
    Günthert U; Stauder R; Mayer B; Terpe HJ; Finke L; Friedrichs K
    Cancer Surv; 1995; 24():19-42. PubMed ID: 7553660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions.
    Shirure VS; Liu T; Delgadillo LF; Cuckler CM; Tees DF; Benencia F; Goetz DJ; Burdick MM
    Am J Physiol Cell Physiol; 2015 Jan; 308(1):C68-78. PubMed ID: 25339657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.